Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Proliferative Diabetic Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Large-scale testing (Phase 3)Looking for participantsNCT06817265
What this trial is testing

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd 360
Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Testing effectiveness (Phase 2)Study completedNCT01552408
What this trial is testing

Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)

Who this might be right for
Diabetic Macular Edema
David M. Brown, M.D. 29
Post-approval studies (Phase 4)Study completedNCT03439345
What this trial is testing

Lowering Events in Non-proliferative Retinopathy in Scotland

Who this might be right for
Diabetic Retinopathy
University of Oxford 1,151
Post-approval studies (Phase 4)Ended earlyNCT00563043
What this trial is testing

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Who this might be right for
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Asociación para Evitar la Ceguera en México 8
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 53
Not applicableNot Yet RecruitingNCT05852132
What this trial is testing

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

Who this might be right for
Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao 249
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Large-scale testing (Phase 3)Study completedNCT02634333
What this trial is testing

Anti-VEGF Treatment for Prevention of PDR/DME

Who this might be right for
Diabetic RetinopathyDiabetic Macular Edema
Jaeb Center for Health Research 399
Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Not applicableStudy completedNCT04636307
What this trial is testing

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Who this might be right for
NPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease
Association for Innovation and Biomedical Research on Light and Image 202
Large-scale testing (Phase 3)Study completedNCT01853072
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 1

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 881
Post-approval studies (Phase 4)WithdrawnNCT04702048
What this trial is testing

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Who this might be right for
Retinopathy, Diabetic
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT04722991
What this trial is testing

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Who this might be right for
Diabetic Retinopathy
Bayer 109
Large-scale testing (Phase 3)Ended earlyNCT00664183
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 400
Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Testing effectiveness (Phase 2)Study completedNCT02435862
What this trial is testing

A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Allegro Ophthalmics, LLC 105
Not applicableStudy completedNCT01440660
What this trial is testing

Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)

Who this might be right for
Type-2 DiabetesDiabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 20
Next Page